Detection of Superoxide in Vascular Tissue
- 1 November 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 22 (11) , 1761-1768
- https://doi.org/10.1161/01.atv.0000034022.11764.ec
Abstract
During the past decade, it has become apparent that reactive oxygen species play a critical role in the genesis of many vascular diseases. The superoxide anion is among the most important of these, not only because of its rapid reaction with NO but also because it serves as a progenitor for many other reactive oxygen species. Although there are many approaches to detecting and quantifying superoxide in chemical systems, its detection in intact tissues is more difficult. The validity of the most popular and frequently used assay for this purpose, lucigenin-enhanced chemiluminescence, has been recently questioned. It has been suggested that lucigenin itself, especially at high concentrations (>50 μmol/L), may act as a source for superoxide via redox cycling. Lower lucigenin concentrations (5 μmol/L) do not participate in redox cycling to an important extent in intact tissues and, therefore, provide an accurate assessment of the rate of superoxide production in such samples. Other useful assays for superoxide include those using the fluorescent dye dihydroethidine, 2-methyl-6-phenyl-3,7-dihydroimidazo(1,2-α)pyrazin-3-one (CLA), and 2-(p-hydroxybenzyl)-6-(p-hydroxyphenyl) 8-benzylimidazo[1,2-α]pyrazin-3-one (coelenterazine). The chemiluminescent compound 5-amino-2,3-dihydroxy-1,4-phthalayineidone (luminol) may also be used to detect various reactive oxygen species and may be made specific for various oxidants, such as hydrogen peroxide, superoxide, and peroxynitrite, by altering the experimental conditions. Although each of these methods may be associated with potential artifacts, the use of ≥2 different techniques that yield similar results provides a reliable approach for the study of reactive oxygen species in intact vascular tissues.Keywords
This publication has 28 references indexed in Scilit:
- Direct enzymatic reduction of lucigenin decreases lucigenin‐amplified chemiluminescence produced by superoxide ionLuminescence, 2001
- Copper,Zinc Superoxide Dismutase as a Univalent NO−Oxidoreductase and as a Dichlorofluorescin PeroxidaseJournal of Biological Chemistry, 2001
- Upregulation of Vascular NAD(P)H Oxidase Subunit gp91phox and Impairment of the Nitric Oxide Signal Transduction Pathway in HypertensionBiochemical and Biophysical Research Communications, 2001
- Evidence for a NADH/NADPH Oxidase in Human Umbilical Vein Endothelial Cells Using Electron Spin ResonanceAntioxidants and Redox Signaling, 2000
- Validation of Lucigenin as a Chemiluminescent Probe to Monitor Vascular Superoxide as Well as Basal Vascular Nitric Oxide ProductionBiochemical and Biophysical Research Communications, 1999
- Quantification of Superoxide Radical Formation in Intact Vascular Tissue Using aCypridinaLuciferin Analog as an Alternative to LucigeninBiochemical and Biophysical Research Communications, 1998
- Acceleration of oxidative stress-induced endothelial cell death by nitric oxide synthase dysfunction accompanied with decrease in tetrahydrobiopterin contentLife Sciences, 1997
- Spin Trapping of Superoxide Radicals and Peroxynitrite by 1-Hydroxy-3-carboxy-pyrrolidine and 1-Hydroxy-2,2,6,6-tetramethyl-4-oxo-piperidine and the Stability of Corresponding Nitroxyl Radicals Towards Biological ReductantsBiochemical and Biophysical Research Communications, 1997
- Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.Journal of Clinical Investigation, 1996
- Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.Journal of Clinical Investigation, 1995